Skip to main content
. 2020 Jul 8;59(5):e193–e197. doi: 10.1016/j.jemermed.2020.07.017

Table 1.

Characteristics of Patients Presenting with Diabetic Ketoacidosis and COVID-19 Infection

Characteristic Case 1 Case 2 Case 3 Case 4 Case 5 Average
Demographic characteristics
 Age (years) 55 57 38 45 63 49
 Sex Male Female Male Female Female
 Body mass index 31.1 19.8 29.1 21.4 36.2 27.5
Patient disease characteristics
 Diabetes medications Glipizide Metformin, glipizide Insulin detemir and aspart None Insulin
 Hemoglobin A1C (%) 9.5 11.3 11.9 15 9.8 11.5
Presentation characteristics
 Heart rate (beats/min) 91 122 129 116 97 114
 Blood pressure (mm Hg) 161/77 128/75 99/68 115/75 150/90 126/74
 Respiratory rate (breaths/min) 55 32 20 18 53 31
 SpO2 (%) 66 on NRB 97 99 100 95 on 6 L 91
 Glasgow Coma Scale score 11 15 15 15 15 14
 Initial glucose (mg/dL) 948 227 399 342 749 533
 pH 7.13 7.11 7.02 6.99 7.21 7.06
 Anion gap 21 24 22 18 18 21
 β-hydroxy butyrate (mmol/L) 0.75 9.36 n/o 7.83 n/o 5.98
COVID-19 laboratory values
 Creatine kinase (units/L) 545 n/o n/o n/o 329 437
 C-reactive protein (mg/dL) >19.0 18.2 n/o n/o >19.0 18.7
 d-dimer (mcg feu/mL) 5.44 1.06 n/o n/o >35.2 13.9
 Ferritin (ng/mL) 1214 337 n/o n/o >16,500 6017
 Fibrinogen 600 n/o n/o n/o n/o
 Lactate dehydrogenase (units/L) 931 n/o n/o n/o 3934 2,433
 Procalcitonin (ng/mL) 1.38 0.16 n/o n/o 3.65 1.73
 Troponin (ng/mL) n/o <0.02 n/o n/o 2.23 1.13
Hospitalization characteristics
 Fluid to gap closure (mL) 2125 4625 3100 5550 6160 3850
 Time to gap closure (min) 38 900 194 720 650 463
 Length of stay (days) 8 4 3 4 4.75
 Outcome Hospitalized at time of printing Discharge home Discharge home Discharge home Death

COVID-19 = coronavirus disease 2019; n/o = not obtained; NRB = non-rebreather mask.

Room air oxygen saturations (SpO2) were not available for all patients.